Skip to main content

FALLO DE RESPUESTA PRIMARIO Y SECUNDARIO A TRATAMIENTO ANTI-TNF EN COLITIS ULCEROSA: PAPEL DE LOS ANTICUERPOS DE MUCOSA MICROBIOTA-ESPECIFICOS Y FARMACO-ESPECIFICOS

PI21/00037

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2021
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO HOSPITAL DEL MAR DE INVESTIGACIONES MEDICAS (FIMIM)
Execution centre INSTITUTO HOSPITAL DEL MAR DE INVESTIGACIONES MEDICAS (IMIM)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Immunomolecular and reactivity landscapes of gut IgA subclasses in homeostasis and inflammatory bowel disease

  • Tejedor Vaquero, Sonia|||0000-0003-2873-4981
  • Neuman, Hadas|||0000-0003-4098-7041
  • Comerma, Laura|||0000-0002-0249-4636
  • Marcos-Fa, Xavi|||0000-0002-4216-1123
  • Corral-Vazquez, Celia|||0000-0002-0621-4590
  • Uzzan, Mathieu|||0000-0002-7761-2879
  • Pybus, Marc|||0000-0002-6195-5738
  • Segura-Garzón, Daniel|||0000-0003-0210-9571
  • Guerra, Joana|||0000-0001-7185-9283
  • Perruzza, Lisa
  • Tachó-Piñot, Roser|||0000-0002-4641-1134
  • Sintes, Jordi|||0000-0002-1836-7076
  • Rosenstein, Adam
  • Grasset, Emilie K.|||0000-0002-9592-1640
  • Iglesias, Mar|||0000-0002-2274-4671
  • Gonzàlez-Farré, Mònica|||0000-0002-0653-0980
  • Lop Gros, Joan|||0000-0002-9442-5688
  • Patriaca-Amiano, Maria Evangelina|||0000-0003-1001-1910
  • Larrubia-Loring, Monica
  • Santiago Díaz, Pablo|||0000-0003-2219-7687
  • Perera-Bel, Júlia|||0000-0002-6809-132X
  • Berenguer-Molins, Pau|||0000-0002-0170-2931
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Varela, Encarna|||0000-0001-6334-9320
  • Garrido-Pontnou, Marta|||0000-0002-7762-7085
  • Grassi, Fabio|||0000-0003-3348-1712
  • Guarner, Francisco|||0000-0002-4051-0836
  • Mehandru, Saurabh|||0000-0001-9781-2969
  • Márquez Mosquera, Lucía|||0000-0002-3182-9570
  • Mehr, Ramit|||0000-0002-4303-6834
  • Cerutti, Andrea|||0000-0003-3026-4704
  • Magri, Giuliana|||0000-0002-0163-3542
Tejedor Vaquero et al. show that gut IgA1 and IgA2 subclasses co-emerge early in life, largely derive from clonally related and somatically mutated plasma cells in adults, and show unique changes of both frequency and reactivity in inflammatory bowel disease. The human gut includes plasma cells (PCs) expressing immunoglobulin A1 (IgA1) or IgA2, two structurally distinct IgA subclasses with elusive regulation, function, and reactivity. We show here that intestinal IgA1 + and IgA2 + PCs co-emerged early in life, comparably accumulated somatic mutations, and were enriched within short-lived CD19 + and long-lived CD19 - PC subsets, respectively. IgA2 + PCs were extensively clonally related to IgA1 + PCs and a subset of them presumably emerged from IgA1 + precursors. Of note, secretory IgA1 (SIgA1) and SIgA2 dually coated a large fraction of mucus-embedded bacteria, including Akkermansia muciniphila. Disruption of homeostasis by inflammatory bowel disease (IBD) was associated with an increase in actively proliferating IgA1 + plasmablasts, a depletion in long-lived IgA2 + PCs, and increased SIgA1 + SIgA2 + gut microbiota. Such increase featured enhanced IgA1 reactivity to pathobionts, including Escherichia coli, combined with depletion of beneficial A. muciniphila. Thus, gut IgA1 and IgA2 emerge from clonally related PCs and show unique changes in both frequency and reactivity in IBD.